Abstract PD1-3: Ph1b study of the PI3K inhibitor GDC-0032 in combination with fulvestrant in patients with hormone receptor-positive advanced breast cancer
暂无分享,去创建一个
J. Baselga | T. Wilson | D. Juric | I. Mayer | J. Sachdev | H. Parmar | A. Cervantes | C. Saura | R. Lin | I. Krop | M. V. Oliveira | D. D. Hoff | R. Graham | Patel | C. Kurkjian | S. Sanabria | S. Cheeti | J. Hsu